Position in IONS
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$1,110
+$59 QoQ
Shares Held
14
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#488
of 510 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IONS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Mascoma Wealth Management LLC holds $19,738 across 8 Biotechnology names. IONS ranks #5 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
14 | $6,954 | |
| 2 | EXEL |
Exelixis, Inc.
|
100 | $5,441 | |
| 3 | FTRE |
Fortrea Holdings Inc.
|
150 | $2,610 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
40 | $2,181 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
This page
|
14 | $1,110 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
9 | $704 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
2 | $632 | |
| 8 | INSM |
INSMED Inc
|
1 | $106 |
All Filings in IONS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,110 | 14 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $1,051 | 14 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $1,107 | 14 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $915 | 14 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $553 | 14 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $422 | 14 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $489 | 14 | Shares | Sole | 2025-02-10 | |
| No filing history on record for this holder in this stock. | ||||||